Love soda? Research says it could boost your liver disease risk by a staggering 60%A recent study presented at the United European Gastroenterology Week in Berlin has discovered that drinking even one can of soda a day, wh...
12 Nov, 2025, 09.58 PM IST
In mid-caps, 'just hold' often creates wealth: 10 mid-cap stocks from different sectors with upside potential up to 44%Just like there is the FOMO (Fear of Missing Out) in terms of buying, there is also panic selling. And panic selling is the bigger enemy of...
13 Jul, 2025, 12.38 AM IST
Long term Alpha generators: 8 mid and small cap stocks from pharma and healthcare sector with an upside potential of up to 27%After a long period of time, recently an Indian pharma company announced its intention to takeover a reasonably sized European company. Thi...
23 Aug, 2024, 12.11 PM IST
Alpha generators in the long term: 9 mid and small cap stocks from pharma and healthcare sector with an upside potential of up to 29%While some make it to the headlines, some don't. Two sectors, healthcare and pharma have been witnessing more mergers and acquisitions than...
18 Jul, 2024, 02.54 PM IST
Weekly Top mid and smallcap picks: These mid and smallcap stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
05 Jul, 2024, 12.50 PM IST
Weekly Top Picks: These mid and small cap stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
28 Jun, 2024, 03.46 PM IST
Weekly Top Picks: These mid and small cap stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
21 Jun, 2024, 02.49 PM IST
Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
27 Apr, 2023, 11.59 AM IST
Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
23 Mar, 2023, 11.46 AM IST
Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
16 Mar, 2023, 11.42 AM IST
Midcap stocks with ‘strong buy’ & ‘buy’ reco which can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
09 Mar, 2023, 12.16 PM IST
Even as bears stay in control of Nifty, midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25%, say analystsNifty in a correction mode and how much time it will stay in that mode, it is anyone's guess. For all those who are busy guessing how thing...
02 Mar, 2023, 12.13 PM IST
Maintain oral health: Painful gums, mouth ulcers can increase risk of liver cancerPoor oral hygiene can also result due to chronic problems like heart disease, stroke and diabetes.
19 Jun, 2019, 12.44 PM IST
Intas closing in on Mallinckrodt’s US generics businessThis comes as US President Donald Trump has declared opioid addiction a public health emergency in the US and drugmakers have found themsel...
08 Nov, 2017, 03.48 PM IST
Five of the most interesting ideas of the week, and the stories behind themCompanies are throwing their efforts into bikes designed for new riders who aren’t enamoured with classic, massive Harleys.
08 Jul, 2017, 12.11 AM IST
Women who undergo IVF at three fold risk of digestive diseaseWomen who give birth to babies conceived by in-vitro fertilisation are three-times more likely to have a common digestive condition.
11 Aug, 2015, 06.39 PM IST
- Zydus Cadila faces patent suit in US over drug Asocol
US based Warner Chilcott Plc has moved court against Zydus Cadila's plan to produce a bowel inflammation drug Asocol.
18 Nov, 2011, 01.13 PM IST